4//SEC Filing
AMGEN INC 4
Accession 0001127602-14-010746
$AMGNCIK 0000318154operating
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 5:23 PM ET
Size
13.2 KB
Accession
0001127602-14-010746
Insider Transaction Report
Form 4
AMGEN INCAMGN
de Carbonnel Francois
Director
Transactions
- Exercise/Conversion
Nqso (Right to Buy)
2014-03-06−5,000→ 0 totalExercise: $58.43From: 2011-04-26Exp: 2020-04-26→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2014-03-06$58.43/sh+5,000$292,150→ 20,364 total - Exercise/Conversion
Common Stock
2014-03-06$50.44/sh+5,000$252,200→ 25,364 total - Tax Payment
Common Stock
2014-03-06$126.19/sh−6,021$759,790→ 19,343 total - Sale
Common Stock
2014-03-06$126.69/sh−1,000$126,690→ 18,343 total - Exercise/Conversion
Nqso (Right to Buy)
2014-03-06−5,000→ 0 totalExercise: $50.44From: 2010-04-28Exp: 2016-04-28→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]All shares were sold at $126.69.
- [F2]These shares include 95 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.
Documents
Issuer
AMGEN INC
CIK 0000318154
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000318154
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 5:23 PM ET
- Size
- 13.2 KB